These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective. Humbert M, Lau EMT. Am J Respir Crit Care Med; 2021 Mar 15; 203(6):675-677. PubMed ID: 33357026 [No Abstract] [Full Text] [Related]
3. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review. Knafl D, Gerges C, King CH, Humbert M, Bustinduy AL. Eur Respir Rev; 2020 Mar 31; 29(155):. PubMed ID: 32024722 [Abstract] [Full Text] [Related]
4. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension. Khirfan G, Almoushref A, Naal T, Abuhalimeh B, Dweik RA, Heresi GA, Tonelli AR. Chest; 2020 Dec 31; 158(6):2546-2555. PubMed ID: 32629034 [Abstract] [Full Text] [Related]
11. Progressive Dyspnea in a Woman with Congenital Heart Disease and Pulmonary Arterial Hypertension. Friedman SH, Veglia M, Gregg D, Argula RG. Ann Am Thorac Soc; 2022 Jul 01; 19(7):1221-1225. PubMed ID: 35772094 [No Abstract] [Full Text] [Related]
12. Prognostic Stratification and Treatment for Pulmonary Arterial Hypertension. Gaps and Promising Remedies. Del Pozo R, Cruz-Utrilla A, Escribano-Subias P. Arch Bronconeumol; 2023 Oct 01; 59(10):617-618. PubMed ID: 37147267 [No Abstract] [Full Text] [Related]
13. The Oracle of the Auricle?: Optimizing Serial Risk Stratification of Patients With Pulmonary Arterial Hypertension. Shelburne NJ, Frantz RP. Chest; 2022 Sep 01; 162(3):509-510. PubMed ID: 36088091 [No Abstract] [Full Text] [Related]
15. The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite? Ford HJ, LeVarge B. Chest; 2021 Jan 01; 159(1):14-16. PubMed ID: 33422195 [No Abstract] [Full Text] [Related]
17. Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension. Richter MJ, Tello K. Am J Respir Crit Care Med; 2020 Feb 15; 201(4):403-405. PubMed ID: 31726011 [No Abstract] [Full Text] [Related]
19. Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment? Singh N, Ventetuolo CE. Am J Respir Crit Care Med; 2022 May 01; 205(9):988-990. PubMed ID: 35143371 [No Abstract] [Full Text] [Related]
20. [Risk stratification methods and their significance in pulmonary arterial hypertension]. Avdeev SN, Tsareva NA. Ter Arkh; 2019 Sep 15; 91(9):150-157. PubMed ID: 32598827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]